Beam Therapeutics Inc. (BEAM) Discusses Topline Phase I/II Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency - Slideshow (NASDAQ:BEAM) 2026-03-27
Beam Therapeutics(US:BEAM) Seeking Alpha·2026-03-27 23:14To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...